Skip to content

HIV/HCV co-infected women more likely to stop HCV therapy

HCV protease inhibitors likely to work for co-infected patients previously treated for HCV

Thai activists call for treatment for hepatitis C for people with HIV

Does nevirapine improve hepatitis C treatment outcomes in HIV/HCV co-infected individuals?

Insulin resistance impairs response to hepatitis C therapy for patients co-infected with HIV

IL28B gene variation predicts response to hepatitis C treatment: will it change treatment of co-infection?

Successful hepatitis C treatment reduces HIV disease progression and non-liver-related mortality

Genetic test predicts who will respond to hepatitis C treatment

Combinations and conundrums: the challenges of hepatitis C treatment